तपेदिक उपचार (Hindi Wikipedia)

Analysis of information sources in references of the Wikipedia article "तपेदिक उपचार" in Hindi language version.

refsWebsite

Global rank Hindi rank

115nih.gov

4^th place

7^th place

74doi.org

2^nd place

5^th place

32archive.org

6^th place

20web.archive.org

1^st place

5wikipedia.org

low place

2,315^th place

5asm.org

3,555^th place

1,210^th place

3uchicago.edu

230^th place

131^st place

3cdc.gov

218^th place

154^th place

2ingenta.com

low place

1jbjs.org.uk

low place

4,802^nd place

1google.co.uk

504^th place

117^th place

1who.int

195^th place

72^nd place

1reuters.com

49^th place

168^th place

1yahoo.com

38^th place

46^th place

1news24.com

1,309^th place

5,988^th place

1nejm.org

2,374^th place

1,475^th place

1bbc.co.uk

8^th place

13^th place

1elsevier.com

610^th place

1,030^th place

1ersjournals.com

low place

1atsjournals.org

low place

8,780^th place

1ingentaconnect.com

3,306^th place

1,309^th place

1periodicals.net.cn

low place

1csis.com.tw

low place

1tballiance.org

low place

1academicjournals.org

low place

1scialert.net

low place

1proactiveinvestors.co.uk

low place

1omicsonline.org

low place

academicjournals.org

Prihoda et al. Archived 2010-11-15 at the वेबैक मशीन Open label trial of adjuvant immunotherapy with Dzherelo, Svitanok and Lizorm, in MDR-TB, XDR-TB and TB/HIV co-infected patients receiving anti-tuberculosis ther... Archived 2010-11-15 at the वेबैक मशीन

archive.org

Elzinga G, Raviglione MC, Maher D (2004). "Scale up: meeting targets in global tuberculosis control". Lancet. 363 (9411): 814–9. डीओआई:10.1016/S0140-6736(04)15698-5. पीएमआईडी 15016493. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Dye C, Watt CJ, Bleed DM, Williams BG (2003). "What is the limit to case detection under the DOTS strategy for tuberculosis control?". Tuberculosis. 83 (1–3): 35–43. डीओआई:10.1016/S14729792(02)00056-2. पीएमआईडी 12758187.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Campbell IA, Ormerod LP, Friend JA, Jenkins PA, Prescott RJ (1993). "Six months versus nine months chemotherapy for tuberculosis of lymph nodes: final results". Respiratory Medicine. 87 (8): 621–3. डीओआई:10.1016/S0954-6111(05)80265-3. पीएमआईडी 8290746. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
"Five-year assessment of controlled trials of short-course chemotherapy regimens of 6, 9 or 18 months' duration for spinal tuberculosis in patients ambulatory from the start or undergoing radical surgery. Fourteenth report of the Medical Research Council Working Party on Tuberculosis of the Spine". International Orthopaedics. 23 (2): 73–81. 1999. पीएमआईडी 10422019.
Kent SJ, Crowe SM, Yung A, Lucas CR, Mijch AM (1993). "Tuberculous Meningitis: A 30-Year Review". Clin Infect Dis. 17 (6): 987–94. पीएमआईडी 8110957.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Teoh R, O'Mahony G, Yeung VTF (1986). "Polymorphonuclear pleocytosis in the cerebrospinal fluid during chemotherapy for tuberculous meningitis". J Neurol. 233 (4): 237–41. डीओआई:10.1007/BF00314027. पीएमआईडी 3746363.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Thwaites GE; et al. (2004). "Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults". N Engl J Med. 351 (17): 1741–51. डीओआई:10.1056/NEJMoa040573. पीएमआईडी 15496623. {{cite journal}}: Explicit use of et al. in: |author= (help)
Purohit SD, Sarkar SK, Gupta ML, Jain DK, Gupta PR, Mehta YR (1987). "Dietary constituents and rifampicin absorption". Tubercle. 68 (2): 151–2. डीओआई:10.1016/0041-3879(87)90034-1. पीएमआईडी 3660467. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Peloquin CA, Namdar R, Singleton MD, Nix DE (1999). "Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids". Chest. 115 (1): 12–8. डीओआई:10.1378/chest.115.1.12. पीएमआईडी 9925057. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Steele MA, Burk RF, DesPrez RM (1991). "Toxic hepatitis with isoniazid and rifampin. A meta-analysis". Chest. 99 (2): 465–71. डीओआई:10.1378/chest.99.2.465. पीएमआईडी 1824929. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Breen RAM, Miller RF, Gorsuch T; et al. (2006). "Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapy". J Infect Dis. 193 (10): 1437–40. डीओआई:10.1086/503437. पीएमआईडी 16619192. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Dukes CS, Sugarman J, Cegielski JP, Lallinger GJ, Mwakyusa DH (1992). "Severe cutaneous hypersensitivity reactions during treatment of tuberculosis in patients with HIV infection in Tanzania". Trop Geogr Med. 44 (4): 308–11. पीएमआईडी 1284179.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Laurie Garrett (2000). Betrayal of trust: the collapse of global public health. New York: Hyperion. p. 268ff. ISBN 0786884407. {{cite book}}: Check |isbn= value: checksum (help)
Gillespie SH (2002). "Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective". Antimicrob Agents Chemother. 46: 267–274. डीओआई:10.1128/AAC.46.2.267-274.2002.
Bang D, Andersen ÅB, Thomsen VØ (2006). "Rapid genotypic detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis directly in clinical specimens". J Clin Microbiol. 44 (7): 2605–2608. डीओआई:10.1128/JCM.00752-06. पीएमसी 1489488. पीएमआईडी 16825393.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Steering Group, Ernesto Jaramillo... (2008). Guidelines for the programmatic management of drug-resistant tuberculosis: emergency update 2008 (WHO/HTM/TB/2008.402). Geneva, Switzerland: World Health Organization. p. 51. ISBN 9789241547581.
Chambers HF, Kocagoz T, Sipit T, Turner J, Hopewell PC. (1998). "Activity of amoxicillin/clavulanate in patients with tuberculosis". Clin Infect Dis. 26 (4): 874–7. डीओआई:10.1086/513945. पीएमआईडी 9564467.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Stover CK, Warrener P, VanDevanter DR; et al. (2000). "A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis". Nature. 405 (6789): 962–6. डीओआई:10.1038/35016103. पीएमआईडी 10879539. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
van Leuven M, De Groot M, Shean KP, von Oppell UO, Willcox PA (1997). "Pulmonary resection as an adjunct in the treatment of multiple drug-resistant tuberculosis". The Annals of thoracic surgery. 63 (5): 1368–72. पीएमआईडी 9146329. {{cite journal}}: Unknown parameter |unused_data= ignored (help)CS1 maint: multiple names: authors list (link)
Pomerantz BJ, Cleveland JC Jr, Olson HK, Pomerantz M (2001). "Pulmonary resection for multi-drug resistant tuberculosis". J Thorac Cardiovasc Surg. 121 (3): 448–453. डीओआई:10.1067/mtc.2001.112339. पीएमआईडी 11241079.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Shiraishi Y, Nakajima Y, Katsuragi N, Kurai M, Takahashi N (2004). "Resectional surgery combined with chemotherapy remains the treatment of choice for multidrug-resistant tuberculosis". J Thorac Cardiovasc Surg. 128 (4): 523–8. डीओआई:10.1016/S0022-5223(04)00871-2. पीएमआईडी 15457152.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Mohsen T, Zeid AA, Haj-Yahia S (2007). "Lobectomy or pneumonectomy for multidrug-resistant pulmonary tuberculosis can be performed with acceptable morbidity and mortality: A seven-year review of a single institution's experience". J Thorac Cardiovasc Surg. 134 (1): 194–198. डीओआई:10.1016/j.jtcvs.2007.03.022. पीएमआईडी 17599508.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Davies PD (1985). "A possible link between vitamin D deficiency and impaired host defence to Mycobacterium tuberculosis". Tubercle. 66 (4): 301–6. डीओआई:10.1016/0041-3879(85)90068-6. पीएमआईडी 3936248.
Brodie MJ, Boobis AR, Hillyard CJ, Abeyasekera G, MacIntyre I, Park BK (1981). "Effect of isoniazid on vitamin D metabolism and hepatic monooxygenase activity". Clin Pharmacol Ther. 30 (3): 363–7. डीओआई:10.1038/clpt.1981.173. पीएमआईडी 7273600.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Brodie MJ, Boobis AR, Hillyard CJ; et al. (1982). "Effect of rifampicin and isoniazid on vitamin D metabolism". Clin Pharmacol Ther. 32 (4): 525–30. डीओआई:10.1038/clpt.1982.197. पीएमआईडी 7116768. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Williams SE, Wardman AG, Taylor GA, Peacock M, Cooke NJ (1985). "Long term study of the effect of rifampicin and isoniazid on vitamin D metabolism". Tubercle. 66 (1): 49–54. डीओआई:10.1016/0041-3879(85)90053-4. पीएमआईडी 3838603.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Wilkinson R, Llewelyn M, Toossi Z; et al. (2000). "Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study". Lancet. 355 (9204): 618–21. डीओआई:10.1016/S0140-6736(99)02301-6. पीएमआईडी 10696983. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Rook GA, Steele J, Fraher L; et al. (1986). "Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes". Immunology. 57: 159–163. पीएमआईडी 3002968. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Crowle AJ, Ross EJ, May MH (1987). "Inhibition by l,25(OH)2-vitamin D3 of the multiplication of virulent tubercle bacilli in cultured human macrophages". Infect Immun. 55: 2945–2950. पीएमआईडी 3119492.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Sly M, Lopez M, Nauseef WM, Reiner NE (2001). "1α,25-dihydroxyvitamin D₃-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase". J Biol Chem. 276: 35482–93.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Martineau AR, Wilkinson KA, Newton SM; et al. (2007). "IFN-γ- and TNF-independent vitamin D-inducible human suppression of mycobacteria: The role of cathelicidin LL-37". J Immunol. 178: 7190–98. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Ijaz K, Jereb JA, Lambert LA; et al. (2006). "Severe of fatal liver injury in 50 patients in the United States taking rifampin and pyrazinamide for latent tuberculosis". Clin Infect Dis. 42 (3): 346–55. डीओआई:10.1086/499244. पीएमआईडी 16392079. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)

asm.org

aac.asm.org

Peloquin CA, Bulpitt AE, Jaresko GS, Jelliffe RW, Childs JM, Nix DE (1999). "Pharmacokinetics of ethambutol under fasting conditions, with food, and with antacids". Antimicrobial Agents and Chemotherapy. 43 (3): 568–72. पीएमसी 89161. पीएमआईडी 10049268. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)^{[मृत कड़ियाँ]}
Adams LM, Sinha I, Franzblau SG; et al. (1999). "Effective treatment of acute and chronic murine tuberculosis with liposome-encapsulated clofazimine" (PDF). Antimicrob Agents Chemother. 43 (7): 1638–43. मूल से (PDF) से 21 जुलाई 2011 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Janulionis, E.; Sofer, C; Song, HY; Wallis, RS (2004). "Lack of activity of orally administered clofazimine against intracellular Mycobacterium tuberculosis in whole-blood culture" (PDF). Antimicrob Agents Chemother. 48 (8): 3133–35. डीओआई:10.1128/AAC.48.8.3133-3135.2004. पीएमसी 478499. पीएमआईडी 15273133. मूल से (PDF) से 21 जुलाई 2011 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011.
Wayne LG, Sramek HA (1994). "Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis". Antimicrob Agents Chemother. 38 (9): 2054–58. डीओआई:10.1128/AAC.. पीएमसी 284683. पीएमआईडी 7811018. मूल से से 5 जनवरी 2011 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011. {{cite journal}}: Check |doi= value (help)

iai.asm.org

Rockett KA, Brookes R, Udalova I; et al. (November 1, 1998). "1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line". Infect Immunity. 66 (11): 5314–21. पीएमसी 108664. पीएमआईडी 9784538. मूल से से 5 जनवरी 2011 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)

atsjournals.org

ajrccm.atsjournals.org

Jagannath C, Reddy MV, Kailasam S, O'Sullivan JF, Gangadharam PR. (April 1, 1995). "Chemotherapeutic activity of clofazimine and its analogues against Mycobacterium tuberculosis. In vitro, intracellular, and in vivo studies". Am J Respir Crit Care Med. 151 (4): 1083–86. पीएमआईडी 7697235. मूल से से 16 जुलाई 2011 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011.{{cite journal}}: CS1 maint: multiple names: authors list (link)

bbc.co.uk

news.bbc.co.uk

"Old drug combination in TB fight". बीबीसी न्यूज़. 27 फ़रवरी 2009. 1 मार्च 2009 को मूल से पुरालेखित. अभिगमन तिथि: 27 फ़रवरी 2009.

cdc.gov

Center for Disease Control (2006). "Emergence of Mycobacterium tuberculosis with Extensive Resistance to Second-Line Drugs — Worldwide, 2000–2004". MMWR Weekly. 55 (11): 301–305. 12 जनवरी 2020 को मूल से पुरालेखित. अभिगमन तिथि: 22 फ़रवरी 2011.
Centers for Diseases Control (2006). "Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000-2004". Morb Mort Wkly Rep. 55: 301–5. 10 मार्च 2010 को मूल से पुरालेखित. अभिगमन तिथि: 22 फ़रवरी 2011.
Migliori GB, Ortmann J, Girardi E; et al. (2007). "Extensively drug-resistant tuberculosis, Italy and Germany". 13 (5). 10 मार्च 2010 को मूल से पुरालेखित. अभिगमन तिथि: 22 फ़रवरी 2011. {{cite journal}}: Cite journal requires |journal= (help); Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)

csis.com.tw

cnki50.csis.com.tw

Li WT, Jiang GN, Gao W, Xiao HP, Ding JA. 李文濤,姜格寧,高文,肖和平,丁嘉安 (2006). "Surgical treatment of multi-drug resistant pulmonary tuberculosis in 188 cases 耐多藥肺結核188例的外科治療". Chinese Journal of Tuberculosis and Respiratory Diseases 中華結核和呼吸雜誌 (चीनी भाषा में). 29 (8): 524–6. पीएमआईडी 17074264. मूल से से 9 जनवरी 2016 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011. {{cite journal}}: External link in |journal= (help)CS1 maint: multiple names: authors list (link)

doi.org

"Streptomycin treatment of pulmonary tuberculosis". British Medical Journal. 2 (4582): 769–82. 1948. डीओआई:10.1136/bmj.2.4582.769. पीएमसी 2091872. पीएमआईडी 18890300. {{cite journal}}: Unknown parameter |month= ignored (help)
Wang JY, Hsueh PR, Jan IS; et al. (2006). "Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas". Thorax. 61 (10): 903–8. डीओआई:10.1136/thx.2005.056887. पीएमसी 2104756. पीएमआईडी 16809417. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Britishthoracicsociety (1984). "A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society". British Journal of Diseases of the Chest. 78 (4): 330–6. डीओआई:10.1016/0007-0971(84)90165-7. पीएमआईडी 6386028. {{cite journal}}: Unknown parameter |month= ignored (help)
Ormerod LP, Horsfield N (1987). "Short-course antituberculous chemotherapy for pulmonary and pleural disease: 5 years' experience in clinical practice". British Journal of Diseases of the Chest. 81 (3): 268–71. डीओआई:10.1016/0007-0971(87)90160-4. पीएमआईडी 3663498. {{cite journal}}: Unknown parameter |month= ignored (help)
Elzinga G, Raviglione MC, Maher D (2004). "Scale up: meeting targets in global tuberculosis control". Lancet. 363 (9411): 814–9. डीओआई:10.1016/S0140-6736(04)15698-5. पीएमआईडी 15016493. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Dye C, Watt CJ, Bleed DM, Williams BG (2003). "What is the limit to case detection under the DOTS strategy for tuberculosis control?". Tuberculosis. 83 (1–3): 35–43. डीओआई:10.1016/S14729792(02)00056-2. पीएमआईडी 12758187.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Grange JM, Zumla A (2002). "The global emergency of tuberculosis: what is the cause?". The Journal of the Royal Society for the Promotion of Health. 122 (2): 78–81. डीओआई:10.1177/146642400212200206. पीएमआईडी 12134771. {{cite journal}}: Unknown parameter |month= ignored (help)
Harries AD, Jahn A, Zachariah R, Enarson D (2008). "Adapting the DOTS framework for tuberculosis control to the management of non-communicable diseases in sub-Saharan Africa". PLoS Medicine. 5 (6): e124. डीओआई:10.1371/journal.pmed.0050124. पीएमआईडी 18547138. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link) CS1 maint: unflagged free DOI (link)
Sterling TR, Lehmann HP, Frieden TR (2003). "Impact of DOTS compared with DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths: decision analysis". BMJ. 326 (7389): 574. डीओआई:10.1136/bmj.326.7389.574. पीएमसी 151519. पीएमआईडी 12637401. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Campbell IA, Ormerod LP, Friend JA, Jenkins PA, Prescott RJ (1993). "Six months versus nine months chemotherapy for tuberculosis of lymph nodes: final results". Respiratory Medicine. 87 (8): 621–3. डीओआई:10.1016/S0954-6111(05)80265-3. पीएमआईडी 8290746. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Upadhyay SS, Saji MJ, Yau AC (1996). "Duration of antituberculosis chemotherapy in conjunction with radical surgery in the management of spinal tuberculosis". Spine. 21 (16): 1898–903. डीओआई:10.1097/00007632-199608150-00014. पीएमआईडी 8875723. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Teoh R, O'Mahony G, Yeung VTF (1986). "Polymorphonuclear pleocytosis in the cerebrospinal fluid during chemotherapy for tuberculous meningitis". J Neurol. 233 (4): 237–41. डीओआई:10.1007/BF00314027. पीएमआईडी 3746363.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Chang AB; et al. (1998). "Central nervous system tuberculosis after resolution of miliary tuberculosis". Pediatr Infect Dis J. 17 (6): 519–523. डीओआई:10.1097/00006454-199806000-00019. पीएमआईडी 9655548. {{cite journal}}: Explicit use of et al. in: |author= (help)
"Tuberculous meningitis: take an aspirin and call me in the morning?". Clin Infect Dis. 51 (12): iv. 2010. डीओआई:10.1086/657238.
Thwaites GE; et al. (2004). "Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults". N Engl J Med. 351 (17): 1741–51. डीओआई:10.1056/NEJMoa040573. पीएमआईडी 15496623. {{cite journal}}: Explicit use of et al. in: |author= (help)
Roberts MT, Mendelson M, Meyer P, Carmichael A, Lever AM (2003). "The use of thalidomide in the treatment of intracranial tuberculomas in adults: two case reports". J Infect. 47 (3): 251–5. डीओआई:10.1016/S0163-4453(03)00077-X. पीएमआईडी 12963389.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Purohit SD, Sarkar SK, Gupta ML, Jain DK, Gupta PR, Mehta YR (1987). "Dietary constituents and rifampicin absorption". Tubercle. 68 (2): 151–2. डीओआई:10.1016/0041-3879(87)90034-1. पीएमआईडी 3660467. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Peloquin CA, Namdar R, Singleton MD, Nix DE (1999). "Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids". Chest. 115 (1): 12–8. डीओआई:10.1378/chest.115.1.12. पीएमआईडी 9925057. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Zent C, Smith P (1995). "Study of the effect of concomitant food on the bioavailability of rifampicin, isoniazid and pyrazinamide". Tubercle and Lung Disease. 76 (2): 109–13. डीओआई:10.1016/0962-8479(95)90551-0. पीएमआईडी 7780091. {{cite journal}}: Unknown parameter |month= ignored (help)
Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, Menzies D (2003). "Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis". American Journal of Respiratory and Critical Care Medicine. 167 (11): 1472–7. डीओआई:10.1164/rccm.200206-626OC. पीएमआईडी 12569078. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Ormerod LP, Horsfield N (1996). "Frequency and type of reactions to antituberculosis drugs: observations in routine treatment". Tubercle and Lung Disease. 77 (1): 37–42. डीओआई:10.1016/S0962-8479(96)90073-8. पीएमआईडी 8733412. {{cite journal}}: Unknown parameter |month= ignored (help)
Forget EJ, Menzies D (2006). "Adverse reactions to first-line antituberculosis drugs". Expert Opinion on Drug Safety. 5 (2): 231–49. डीओआई:10.1517/14740338.5.2.231. पीएमआईडी 16503745. {{cite journal}}: Unknown parameter |month= ignored (help)
Steele MA, Burk RF, DesPrez RM (1991). "Toxic hepatitis with isoniazid and rifampin. A meta-analysis". Chest. 99 (2): 465–71. डीओआई:10.1378/chest.99.2.465. पीएमआईडी 1824929. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
O'Riordan P, Schwab U, Logan S; et al. (2008). "Rapid molecular detection of rifampicin resistance facilitates early diagnosis and treatment of multidrug-resistant tuberculosis: case control study". PLoS ONE. 3 (9): e3173. डीओआई:10.1371/journal.pone.0003173. पीएमसी 2526158. पीएमआईडी 18779863. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link) CS1 maint: unflagged free DOI (link)
Drobac PC; et al. (2005). "Treatment of Multidrug-Resistant Tuberculosis during Pregnancy: Long-Term Follow-Up of 6 Children with Intrauterine Exposure to Second-Line Agents" (– ^{Scholar search}). Clin Infect Dis. 40 (11): 1689–92. डीओआई:10.1086/430066. पीएमआईडी 15889370. {{cite journal}}: Explicit use of et al. in: |author= (help); External link in |format= (help) ^{[मृत कड़ियाँ]}
Palacios E, Dallman R, Muñoz M; et al. (2009). "Drug‐resistant tuberculosis and pregnancy: Treatment outcomes of 38 cases in Lima, Peru". Clin Infect Dis. 48 (10): 1413–1419. डीओआई:10.1086/598191. पीएमआईडी 19361302. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Breen RAM, Miller RF, Gorsuch T; et al. (2006). "Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapy". J Infect Dis. 193 (10): 1437–40. डीओआई:10.1086/503437. पीएमआईडी 16619192. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Jenny‐Avital1 ER, Joseph K (2009). "Rifamycin‐resistant Mycobacterium tuberculosis in the highly active antiretroviral therapy era: A report of 3 relapses with acquired rifampin resistance following alternate‐day rifabutin and boosted protease inhibitor therapy". Clin Infect Dis. 48 (10): 1471–1474. डीओआई:10.1086/598336. पीएमआईडी 19368504.{{cite journal}}: CS1 maint: numeric names: authors list (link)
Frieden TR, Sterling T, Pablos-Mendez A; et al. (1993). "The emergence of drug-resistant tuberculosis in New York City". N Engl J Med. 328 (8): 521–56. डीओआई:10.1056/NEJM199302253280801. पीएमआईडी 8381207. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Gandhi NR, Moll A, Sturm AW; et al. (2006). "Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa". Lancet. 368: 1575–80. डीओआई:10.1016/S0140-6736(06)69573-1. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Sidley P. (2006). "South Africa acts to curb spread of lethal strain of TB". Brit Med J. 333 (7573): 825. डीओआई:10.1136/bmj.333.7573.825-a. पीएमसी 1618468. पीएमआईडी 17053232.
Singh JA, Upshur R, Padayatchi N. (2007). "XDR-TB in South Africa: No Time for Denial or Complacency". PLoS Med. 4 (1): e50. डीओआई:10.1371/journal.pmed.0040050. पीएमसी 1779818. पीएमआईडी 17253901.{{cite journal}}: CS1 maint: multiple names: authors list (link) CS1 maint: unflagged free DOI (link)
Orenstein EW, Basu S, Shah NS; et al. (2009). "Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis". Lancet Infect Dis. 9 (3): 153–161. डीओआई:10.1016/S1473-3099(09)70041-6. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Mitnick C; et al. (2003). "Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru". N Eng J Med. 348 (2): 119–128. डीओआई:10.1056/NEJMoa022928. पीएमआईडी 12519922. 18 फ़रवरी 2009 को मूल से पुरालेखित. अभिगमन तिथि: 22 फ़रवरी 2011. {{cite journal}}: Explicit use of et al. in: |author= (help)
Gillespie SH (2002). "Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective". Antimicrob Agents Chemother. 46: 267–274. डीओआई:10.1128/AAC.46.2.267-274.2002.
Bang D, Andersen ÅB, Thomsen VØ (2006). "Rapid genotypic detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis directly in clinical specimens". J Clin Microbiol. 44 (7): 2605–2608. डीओआई:10.1128/JCM.00752-06. पीएमसी 1489488. पीएमआईडी 16825393.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Aktas E, Durmaz R, Yang D, Yang Z (2005). "Molecular characterization of isoniazid and rifampin resistance of Mycobacterium tuberculosis clinical isolates from Malatya, Turkey". Microbial Drug Resistance. 11 (2): 94–99. डीओआई:10.1089/mdr.2005.11.94. पीएमआईडी 15910221.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Ziganshina LE, Vizel AA, Squire SB. (2005). "Fluoroquinolones for treating tuberculosis". Cochrane Database Sys Rev (3): CD004795. डीओआई:10.1002/14651858.CD004795.pub2. पीएमआईडी 16034951.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Leimane V.; et al. (2005). "Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study". Lancet. 365 (9456): 318–26. डीओआई:10.1016/S0140-6736(05)17786-1. पीएमआईडी 15664227. {{cite journal}}: Explicit use of et al. in: |author= (help)
Schön T, Elias D, Moges F; et al. (2003). "Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis". Eur Respir J. 21 (3): 483–88. डीओआई:10.1183/09031936.03.00090702. पीएमआईडी 12662006. मूल से से 19 जनवरी 2010 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Chambers HF, Turner J, Schecter GF, Kawamura M, Hopewell PC. (2005). "Imipenem for treatment of tuberculosis in mice and humans". Antimicrob Agents Chemother. 49 (7): 2816–21. डीओआई:10.1128/AAC.49.7.2816-2821.2005. पीएमसी 1168716. पीएमआईडी 15980354.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Chambers HF, Kocagoz T, Sipit T, Turner J, Hopewell PC. (1998). "Activity of amoxicillin/clavulanate in patients with tuberculosis". Clin Infect Dis. 26 (4): 874–7. डीओआई:10.1086/513945. पीएमआईडी 9564467.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Donald PR, Sirgel FA, Venter A; et al. (2001). "Early bactericidal activity of amoxicillin in combination with clavulanic acid in patients with sputum smear-positive pulmonary tuberculosis". Scand J Infect Dis. 33 (6): 466–9. डीओआई:10.1080/00365540152029954. पीएमआईडी 11450868. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Janulionis, E.; Sofer, C; Song, HY; Wallis, RS (2004). "Lack of activity of orally administered clofazimine against intracellular Mycobacterium tuberculosis in whole-blood culture" (PDF). Antimicrob Agents Chemother. 48 (8): 3133–35. डीओआई:10.1128/AAC.48.8.3133-3135.2004. पीएमसी 478499. पीएमआईडी 15273133. मूल से (PDF) से 21 जुलाई 2011 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011.
Wayne LG, Sramek HA (1994). "Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis". Antimicrob Agents Chemother. 38 (9): 2054–58. डीओआई:10.1128/AAC.. पीएमसी 284683. पीएमआईडी 7811018. मूल से से 5 जनवरी 2011 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011. {{cite journal}}: Check |doi= value (help)
Stover CK, Warrener P, VanDevanter DR; et al. (2000). "A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis". Nature. 405 (6789): 962–6. डीओआई:10.1038/35016103. पीएमआईडी 10879539. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Andries K, Verhasselt P, Guillemont J; et al. (2005). "A diarylquinoline drug active on the ATP-synthase of Mycobacterium tuberculosis". Science. 307 (5707): 223–27. डीओआई:10.1126/science.1106753. पीएमआईडी 15591164. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Tam, Cheuk-Ming; Yew, Wing-Wai; Yuen, Kwok-Yung (2009). "Treatment of multidrug-resistant and extensively drug-resistant tuberculosis: current status and future prospects". Expert Review of Clinical Pharmacology. 2: 405–421. डीओआई:10.1586/ecp.09.19. {{cite journal}}: Unknown parameter |unused_data= ignored (help)
Chan ED, Laurel V, Strand MJ; et al. (2004). "Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis". Am J Resp Crit Care Med. 169 (10): 1103–1109. डीओआई:10.1164/rccm.200308-1159OC. पीएमआईडी 14742301. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Sung SW, Kang CH, Kim YT, Han SK, Shim YS, Kim JH (1999). "Surgery increased the chance of cure in multi-drug resistant pulmonary tuberculosis". Eur J Cardiothorac Surg. 16 (2): 187–93. डीओआई:10.1016/S1010-7940(99)00158-X. पीएमआईडी 10485419.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Pomerantz BJ, Cleveland JC Jr, Olson HK, Pomerantz M (2001). "Pulmonary resection for multi-drug resistant tuberculosis". J Thorac Cardiovasc Surg. 121 (3): 448–453. डीओआई:10.1067/mtc.2001.112339. पीएमआईडी 11241079.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Shiraishi Y, Nakajima Y, Katsuragi N, Kurai M, Takahashi N (2004). "Resectional surgery combined with chemotherapy remains the treatment of choice for multidrug-resistant tuberculosis". J Thorac Cardiovasc Surg. 128 (4): 523–8. डीओआई:10.1016/S0022-5223(04)00871-2. पीएमआईडी 15457152.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Mohsen T, Zeid AA, Haj-Yahia S (2007). "Lobectomy or pneumonectomy for multidrug-resistant pulmonary tuberculosis can be performed with acceptable morbidity and mortality: A seven-year review of a single institution's experience". J Thorac Cardiovasc Surg. 134 (1): 194–198. डीओआई:10.1016/j.jtcvs.2007.03.022. पीएमआईडी 17599508.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Zachariah R, Spielmann MP, Harries AD, Salaniponi FM. (2002). "Moderate to severe malnutrition in patients with tuberculosis is a risk factor associated with early death". Trans R Soc Trop Med Hyg. 96 (3): 291–4. डीओआई:10.1016/S0035-9203(02)90103-3. पीएमआईडी 12174782.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Nnoaham KE, Clarke A (2008). "Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis". Int J Epidemiol. 37 (1): 113–9. डीओआई:10.1093/ije/dym247. पीएमआईडी 18245055.
Davies PD (1985). "A possible link between vitamin D deficiency and impaired host defence to Mycobacterium tuberculosis". Tubercle. 66 (4): 301–6. डीओआई:10.1016/0041-3879(85)90068-6. पीएमआईडी 3936248.
Vieth R (2011). "Vitamin D nutrient to treat TB begs the prevention question". Lancet. 377 (9761): 189, 190. डीओआई:10.1016/S0140-6736(10)62300-8.
Liu PT, Stenger S, Li H; et al. (2006). "Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response". Science. 311 (5768): 1770–3. डीओआई:10.1126/science.1123933. पीएमआईडी 16497887. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Brodie MJ, Boobis AR, Hillyard CJ, Abeyasekera G, MacIntyre I, Park BK (1981). "Effect of isoniazid on vitamin D metabolism and hepatic monooxygenase activity". Clin Pharmacol Ther. 30 (3): 363–7. डीओआई:10.1038/clpt.1981.173. पीएमआईडी 7273600.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Brodie MJ, Boobis AR, Hillyard CJ; et al. (1982). "Effect of rifampicin and isoniazid on vitamin D metabolism". Clin Pharmacol Ther. 32 (4): 525–30. डीओआई:10.1038/clpt.1982.197. पीएमआईडी 7116768. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Williams SE, Wardman AG, Taylor GA, Peacock M, Cooke NJ (1985). "Long term study of the effect of rifampicin and isoniazid on vitamin D metabolism". Tubercle. 66 (1): 49–54. डीओआई:10.1016/0041-3879(85)90053-4. पीएमआईडी 3838603.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Bellamy R, Ruwende C, Corrah T; et al. (1998). "Tuberculosis and chronic hepatitis B virus infection in africans and variation in the vitamin D receptor gene". J Infect Dis. 179 (3): 721–24. डीओआई:10.1086/314614. पीएमआईडी 9952386. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Wilkinson R, Llewelyn M, Toossi Z; et al. (2000). "Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study". Lancet. 355 (9204): 618–21. डीओआई:10.1016/S0140-6736(99)02301-6. पीएमआईडी 10696983. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Spector SA (2009). "Vitamin D earns more than a passing grade". J Infect Dis. 200 (7): 1015–1017. डीओआई:10.1086/605723. पीएमआईडी 19673648.
Martineau AR, Wilkinson RJ, Wilkinson KA, Newton SM, Kampmann B, Hall BM; et al. (2007). "A single dose of vitamin D enhances immunity to Mycobacteria". Am J Respir Crit Care Med. 176 (2): 208–13. डीओआई:10.1164/rccm.200701-007OC. पीएमआईडी 17463418. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Schechter M, Zajdenverg R, Falco G, Barnes G, Faulhaber J, Coberly J, Moore R, Chaisson R (2006). "Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts". Am J Respir Crit Care Med. 173 (8): 922–6. डीओआई:10.1164/rccm.200512-1953OC. पीएमसी 2662911. पीएमआईडी 16474028.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Ijaz K, Jereb JA, Lambert LA; et al. (2006). "Severe of fatal liver injury in 50 patients in the United States taking rifampin and pyrazinamide for latent tuberculosis". Clin Infect Dis. 42 (3): 346–55. डीओआई:10.1086/499244. पीएमआईडी 16392079. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Nuermberger EL, Yoshimatsu T, Tyagi S; et al. (2004). "Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine Tuberculosis". Am J Resp Crit Care Med. 169 (3): 421–26. डीओआई:10.1164/rccm.200310-1380OC. पीएमआईडी 14578218. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Gosling RD, Uiso LO, Sam NE; et al. (2003). "The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis". Am J Resp Crit Care Med. 168 (11): 1342–45. डीओआई:10.1164/rccm.200305-682OC. पीएमआईडी 12917230. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Nuermberger EL, Yoshimatsu T, Tyagi S; et al. (2004). "Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis". Am J Resp Crit Care Med. 170 (10): 1131–34. डीओआई:10.1164/rccm.200407-885OC. पीएमआईडी 15306535. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Zaitzeva SI, Matveeva SL, Gerasimova TG; et al. (2009). "Treatment of cavitary and infiltrating pulmonary tuberculosis with and without the immunomodulator Dzherelo". Clinical Microbiology and Infection. 15 (12): 1154–62. डीओआई:10.1111/j.1469-0691.2009.02760.x. पीएमआईडी 19456829. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Nikolaeva LG, Maystat TV, Pylypchuk VS, Volyanskii YL, Frolov VM, Kutsyna GA (2008). "Cytokine profiles of HIV patients with pulmonary tuberculosis resulting from adjunct immunotherapy with herbal phytoconcentrates Dzherelo and Anemin". Cytokine. 44 (3): 392–6. डीओआई:10.1016/j.cyto.2008.10.009. पीएमआईडी 19027322. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Nikolaeva LG, Maystat TV, Pylypchuk VS, Volyanskii YL, Masyuk LA, Kutsyna GA (2008). "Effect of oral immunomodulator Dzherelo in TB/HIV co-infected patients receiving anti-tuberculosis therapy under DOTS". International Immunopharmacology. 8 (6): 845–51. डीओआई:10.1016/j.intimp.2008.01.029. पीएमआईडी 18442788. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Olga V. Arjanova; Athalia D. Prihoda1; Larisa V. Yurchenko1; Nina I. Sokolenko1; Valery M. Frolov; Marina G Tarakanovskaya; Vichai Jirathitikal; Aldar S. Bourinbaiar (अक्टूबर 9, 2010). "Phase 2 Trial of V-5 Immunitor (V5) in Patients with Chronic Hepatitis C Co-infected with HIV and Mycobacterium Tuberculosis". Journal of Vaccines and Vaccination. 1 (103). डीओआई:10.4172/2157-7560.1000103. मूल से से 1 जनवरी 2011 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011.{{cite journal}}: CS1 maint: numeric names: authors list (link) CS1 maint: unflagged free DOI (link)

elsevier.com

linkinghub.elsevier.com

Leimane V.; et al. (2005). "Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study". Lancet. 365 (9456): 318–26. डीओआई:10.1016/S0140-6736(05)17786-1. पीएमआईडी 15664227. {{cite journal}}: Explicit use of et al. in: |author= (help)

ersjournals.com

erj.ersjournals.com

Schön T, Elias D, Moges F; et al. (2003). "Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis". Eur Respir J. 21 (3): 483–88. डीओआई:10.1183/09031936.03.00090702. पीएमआईडी 12662006. मूल से से 19 जनवरी 2010 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)

google.co.uk

scholar.google.co.uk

Drobac PC; et al. (2005). "Treatment of Multidrug-Resistant Tuberculosis during Pregnancy: Long-Term Follow-Up of 6 Children with Intrauterine Exposure to Second-Line Agents" (– ^{Scholar search}). Clin Infect Dis. 40 (11): 1689–92. डीओआई:10.1086/430066. पीएमआईडी 15889370. {{cite journal}}: Explicit use of et al. in: |author= (help); External link in |format= (help) ^{[मृत कड़ियाँ]}

ingenta.com

openurl.ingenta.com

Iseman MD (1998). "MDR-TB and the developing world--a problem no longer to be ignored: the WHO announces 'DOTS Plus' strategy". The International Journal of Tuberculosis and Lung Disease. 2 (11): 867. पीएमआईडी 9848604. {{cite journal}}: Unknown parameter |month= ignored (help)
Peloquin CA, Namdar R, Dodge AA, Nix DE (1999). "Pharmacokinetics of isoniazid under fasting conditions, with food, and with antacids". The International Journal of Tuberculosis and Lung Disease. 3 (8): 703–10. पीएमआईडी 10460103. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)

ingentaconnect.com

Harries AD; Hargreaves NJ, Kumwenda J, Kwanjana1 JH, Salaniponi1 FM (2000). "Trials of anti-tuberculosis treatment in areas of high human immunodeficiency virus prevalence in sub-Saharan Africa". Int J Tuberc Lung Dis. 4 (11): 998–1001. पीएमआईडी 11092710. 6 जून 2011 को मूल से पुरालेखित. अभिगमन तिथि: 22 फ़रवरी 2011.{{cite journal}}: CS1 maint: multiple names: authors list (link) CS1 maint: numeric names: authors list (link)

jbjs.org.uk

Parthasarathy R, Sriram K, Santha T, Prabhakar R, Somasundaram PR, Sivasubramanian S (1999). "Short-course chemotherapy for tuberculosis of the spine. A comparison between ambulant treatment and radical surgery--ten-year report". The Journal of Bone and Joint Surgery. British Volume. 81 (3): 464–71. पीएमआईडी 10872368. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)^{[मृत कड़ियाँ]}

nejm.org

content.nejm.org

Mitnick C; et al. (2003). "Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru". N Eng J Med. 348 (2): 119–128. डीओआई:10.1056/NEJMoa022928. पीएमआईडी 12519922. 18 फ़रवरी 2009 को मूल से पुरालेखित. अभिगमन तिथि: 22 फ़रवरी 2011. {{cite journal}}: Explicit use of et al. in: |author= (help)

news24.com

News24. 2-7-1442_2035020,00.html "300+ cases of killer TB in SA". अभिगमन तिथि: 2006-11-23. {{cite web}}: Check |url= value (help)CS1 maint: numeric names: authors list (link)^{[मृत कड़ियाँ]}

nih.gov

pubmed.ncbi.nlm.nih.gov

"Streptomycin treatment of pulmonary tuberculosis". British Medical Journal. 2 (4582): 769–82. 1948. डीओआई:10.1136/bmj.2.4582.769. पीएमसी 2091872. पीएमआईडी 18890300. {{cite journal}}: Unknown parameter |month= ignored (help)
Wang JY, Hsueh PR, Jan IS; et al. (2006). "Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas". Thorax. 61 (10): 903–8. डीओआई:10.1136/thx.2005.056887. पीएमसी 2104756. पीएमआईडी 16809417. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
David HL (1970). "Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis". Applied Microbiology. 20 (5): 810–4. पीएमसी 377053. पीएमआईडी 4991927. {{cite journal}}: Unknown parameter |month= ignored (help)
Britishthoracicsociety (1984). "A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society". British Journal of Diseases of the Chest. 78 (4): 330–6. डीओआई:10.1016/0007-0971(84)90165-7. पीएमआईडी 6386028. {{cite journal}}: Unknown parameter |month= ignored (help)
Ormerod LP, Horsfield N (1987). "Short-course antituberculous chemotherapy for pulmonary and pleural disease: 5 years' experience in clinical practice". British Journal of Diseases of the Chest. 81 (3): 268–71. डीओआई:10.1016/0007-0971(87)90160-4. पीएमआईडी 3663498. {{cite journal}}: Unknown parameter |month= ignored (help)
Elzinga G, Raviglione MC, Maher D (2004). "Scale up: meeting targets in global tuberculosis control". Lancet. 363 (9411): 814–9. डीओआई:10.1016/S0140-6736(04)15698-5. पीएमआईडी 15016493. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Cohn DL, Catlin BJ, Peterson KL, Judson FN, Sbarbaro JA (1990). "A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. A twice-weekly, directly observed, and cost-effective regimen". Annals of Internal Medicine. 112 (6): 407–15. पीएमआईडी 2106816. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Dye C, Watt CJ, Bleed DM, Williams BG (2003). "What is the limit to case detection under the DOTS strategy for tuberculosis control?". Tuberculosis. 83 (1–3): 35–43. डीओआई:10.1016/S14729792(02)00056-2. पीएमआईडी 12758187.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Grange JM, Zumla A (2002). "The global emergency of tuberculosis: what is the cause?". The Journal of the Royal Society for the Promotion of Health. 122 (2): 78–81. डीओआई:10.1177/146642400212200206. पीएमआईडी 12134771. {{cite journal}}: Unknown parameter |month= ignored (help)
Harries AD, Jahn A, Zachariah R, Enarson D (2008). "Adapting the DOTS framework for tuberculosis control to the management of non-communicable diseases in sub-Saharan Africa". PLoS Medicine. 5 (6): e124. डीओआई:10.1371/journal.pmed.0050124. पीएमआईडी 18547138. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link) CS1 maint: unflagged free DOI (link)
Iseman MD (1998). "MDR-TB and the developing world--a problem no longer to be ignored: the WHO announces 'DOTS Plus' strategy". The International Journal of Tuberculosis and Lung Disease. 2 (11): 867. पीएमआईडी 9848604. {{cite journal}}: Unknown parameter |month= ignored (help)
Sterling TR, Lehmann HP, Frieden TR (2003). "Impact of DOTS compared with DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths: decision analysis". BMJ. 326 (7389): 574. डीओआई:10.1136/bmj.326.7389.574. पीएमसी 151519. पीएमआईडी 12637401. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Campbell IA, Ormerod LP, Friend JA, Jenkins PA, Prescott RJ (1993). "Six months versus nine months chemotherapy for tuberculosis of lymph nodes: final results". Respiratory Medicine. 87 (8): 621–3. डीओआई:10.1016/S0954-6111(05)80265-3. पीएमआईडी 8290746. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Upadhyay SS, Saji MJ, Yau AC (1996). "Duration of antituberculosis chemotherapy in conjunction with radical surgery in the management of spinal tuberculosis". Spine. 21 (16): 1898–903. डीओआई:10.1097/00007632-199608150-00014. पीएमआईडी 8875723. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
"Five-year assessment of controlled trials of short-course chemotherapy regimens of 6, 9 or 18 months' duration for spinal tuberculosis in patients ambulatory from the start or undergoing radical surgery. Fourteenth report of the Medical Research Council Working Party on Tuberculosis of the Spine". International Orthopaedics. 23 (2): 73–81. 1999. पीएमआईडी 10422019.
Parthasarathy R, Sriram K, Santha T, Prabhakar R, Somasundaram PR, Sivasubramanian S (1999). "Short-course chemotherapy for tuberculosis of the spine. A comparison between ambulant treatment and radical surgery--ten-year report". The Journal of Bone and Joint Surgery. British Volume. 81 (3): 464–71. पीएमआईडी 10872368. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)^{[मृत कड़ियाँ]}
Kent SJ, Crowe SM, Yung A, Lucas CR, Mijch AM (1993). "Tuberculous Meningitis: A 30-Year Review". Clin Infect Dis. 17 (6): 987–94. पीएमआईडी 8110957.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Teoh R, O'Mahony G, Yeung VTF (1986). "Polymorphonuclear pleocytosis in the cerebrospinal fluid during chemotherapy for tuberculous meningitis". J Neurol. 233 (4): 237–41. डीओआई:10.1007/BF00314027. पीएमआईडी 3746363.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Chang AB; et al. (1998). "Central nervous system tuberculosis after resolution of miliary tuberculosis". Pediatr Infect Dis J. 17 (6): 519–523. डीओआई:10.1097/00006454-199806000-00019. पीएमआईडी 9655548. {{cite journal}}: Explicit use of et al. in: |author= (help)
Thwaites GE; et al. (2004). "Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults". N Engl J Med. 351 (17): 1741–51. डीओआई:10.1056/NEJMoa040573. पीएमआईडी 15496623. {{cite journal}}: Explicit use of et al. in: |author= (help)
Roberts MT, Mendelson M, Meyer P, Carmichael A, Lever AM (2003). "The use of thalidomide in the treatment of intracranial tuberculomas in adults: two case reports". J Infect. 47 (3): 251–5. डीओआई:10.1016/S0163-4453(03)00077-X. पीएमआईडी 12963389.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Purohit SD, Sarkar SK, Gupta ML, Jain DK, Gupta PR, Mehta YR (1987). "Dietary constituents and rifampicin absorption". Tubercle. 68 (2): 151–2. डीओआई:10.1016/0041-3879(87)90034-1. पीएमआईडी 3660467. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Peloquin CA, Namdar R, Singleton MD, Nix DE (1999). "Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids". Chest. 115 (1): 12–8. डीओआई:10.1378/chest.115.1.12. पीएमआईडी 9925057. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Siegler DI, Bryant M, Burley DM, Citron KM, Standen SM (1974). "Effect of meals on rifampicin absorption". Lancet. 2 (7874): 197–8. पीएमआईडी 4135611. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Peloquin CA, Namdar R, Dodge AA, Nix DE (1999). "Pharmacokinetics of isoniazid under fasting conditions, with food, and with antacids". The International Journal of Tuberculosis and Lung Disease. 3 (8): 703–10. पीएमआईडी 10460103. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Joshi MV, Saraf YS, Kshirsagar NA, Acharya VN (1991). "Food reduces isoniazid bioavailability in normal volunteers". The Journal of the Association of Physicians of India. 39 (6): 470–1. पीएमआईडी 1938852. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Zent C, Smith P (1995). "Study of the effect of concomitant food on the bioavailability of rifampicin, isoniazid and pyrazinamide". Tubercle and Lung Disease. 76 (2): 109–13. डीओआई:10.1016/0962-8479(95)90551-0. पीएमआईडी 7780091. {{cite journal}}: Unknown parameter |month= ignored (help)
Peloquin CA, Bulpitt AE, Jaresko GS, Jelliffe RW, James GT, Nix DE (1998). "Pharmacokinetics of pyrazinamide under fasting conditions, with food, and with antacids". Pharmacotherapy. 18 (6): 1205–11. पीएमआईडी 9855317.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Peloquin CA, Bulpitt AE, Jaresko GS, Jelliffe RW, Childs JM, Nix DE (1999). "Pharmacokinetics of ethambutol under fasting conditions, with food, and with antacids". Antimicrobial Agents and Chemotherapy. 43 (3): 568–72. पीएमसी 89161. पीएमआईडी 10049268. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)^{[मृत कड़ियाँ]}
Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, Menzies D (2003). "Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis". American Journal of Respiratory and Critical Care Medicine. 167 (11): 1472–7. डीओआई:10.1164/rccm.200206-626OC. पीएमआईडी 12569078. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Ormerod LP, Horsfield N (1996). "Frequency and type of reactions to antituberculosis drugs: observations in routine treatment". Tubercle and Lung Disease. 77 (1): 37–42. डीओआई:10.1016/S0962-8479(96)90073-8. पीएमआईडी 8733412. {{cite journal}}: Unknown parameter |month= ignored (help)
Forget EJ, Menzies D (2006). "Adverse reactions to first-line antituberculosis drugs". Expert Opinion on Drug Safety. 5 (2): 231–49. डीओआई:10.1517/14740338.5.2.231. पीएमआईडी 16503745. {{cite journal}}: Unknown parameter |month= ignored (help)
Steele MA, Burk RF, DesPrez RM (1991). "Toxic hepatitis with isoniazid and rifampin. A meta-analysis". Chest. 99 (2): 465–71. डीओआई:10.1378/chest.99.2.465. पीएमआईडी 1824929. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
O'Riordan P, Schwab U, Logan S; et al. (2008). "Rapid molecular detection of rifampicin resistance facilitates early diagnosis and treatment of multidrug-resistant tuberculosis: case control study". PLoS ONE. 3 (9): e3173. डीओआई:10.1371/journal.pone.0003173. पीएमसी 2526158. पीएमआईडी 18779863. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link) CS1 maint: unflagged free DOI (link)
Drobac PC; et al. (2005). "Treatment of Multidrug-Resistant Tuberculosis during Pregnancy: Long-Term Follow-Up of 6 Children with Intrauterine Exposure to Second-Line Agents" (– ^{Scholar search}). Clin Infect Dis. 40 (11): 1689–92. डीओआई:10.1086/430066. पीएमआईडी 15889370. {{cite journal}}: Explicit use of et al. in: |author= (help); External link in |format= (help) ^{[मृत कड़ियाँ]}
Palacios E, Dallman R, Muñoz M; et al. (2009). "Drug‐resistant tuberculosis and pregnancy: Treatment outcomes of 38 cases in Lima, Peru". Clin Infect Dis. 48 (10): 1413–1419. डीओआई:10.1086/598191. पीएमआईडी 19361302. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Breen RAM, Miller RF, Gorsuch T; et al. (2006). "Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapy". J Infect Dis. 193 (10): 1437–40. डीओआई:10.1086/503437. पीएमआईडी 16619192. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Jenny‐Avital1 ER, Joseph K (2009). "Rifamycin‐resistant Mycobacterium tuberculosis in the highly active antiretroviral therapy era: A report of 3 relapses with acquired rifampin resistance following alternate‐day rifabutin and boosted protease inhibitor therapy". Clin Infect Dis. 48 (10): 1471–1474. डीओआई:10.1086/598336. पीएमआईडी 19368504.{{cite journal}}: CS1 maint: numeric names: authors list (link)
Dukes CS, Sugarman J, Cegielski JP, Lallinger GJ, Mwakyusa DH (1992). "Severe cutaneous hypersensitivity reactions during treatment of tuberculosis in patients with HIV infection in Tanzania". Trop Geogr Med. 44 (4): 308–11. पीएमआईडी 1284179.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Kuaban C, Bercion R, Koulla-Shiro S (1997). "HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon". East Afr Med J. 74 (8): 474–7. पीएमआईडी 9487410.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Frieden TR, Sterling T, Pablos-Mendez A; et al. (1993). "The emergence of drug-resistant tuberculosis in New York City". N Engl J Med. 328 (8): 521–56. डीओआई:10.1056/NEJM199302253280801. पीएमआईडी 8381207. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Sidley P. (2006). "South Africa acts to curb spread of lethal strain of TB". Brit Med J. 333 (7573): 825. डीओआई:10.1136/bmj.333.7573.825-a. पीएमसी 1618468. पीएमआईडी 17053232.
Singh JA, Upshur R, Padayatchi N. (2007). "XDR-TB in South Africa: No Time for Denial or Complacency". PLoS Med. 4 (1): e50. डीओआई:10.1371/journal.pmed.0040050. पीएमसी 1779818. पीएमआईडी 17253901.{{cite journal}}: CS1 maint: multiple names: authors list (link) CS1 maint: unflagged free DOI (link)
Mitnick C; et al. (2003). "Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru". N Eng J Med. 348 (2): 119–128. डीओआई:10.1056/NEJMoa022928. पीएमआईडी 12519922. 18 फ़रवरी 2009 को मूल से पुरालेखित. अभिगमन तिथि: 22 फ़रवरी 2011. {{cite journal}}: Explicit use of et al. in: |author= (help)
Bang D, Andersen ÅB, Thomsen VØ (2006). "Rapid genotypic detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis directly in clinical specimens". J Clin Microbiol. 44 (7): 2605–2608. डीओआई:10.1128/JCM.00752-06. पीएमसी 1489488. पीएमआईडी 16825393.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Aktas E, Durmaz R, Yang D, Yang Z (2005). "Molecular characterization of isoniazid and rifampin resistance of Mycobacterium tuberculosis clinical isolates from Malatya, Turkey". Microbial Drug Resistance. 11 (2): 94–99. डीओआई:10.1089/mdr.2005.11.94. पीएमआईडी 15910221.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Ziganshina LE, Vizel AA, Squire SB. (2005). "Fluoroquinolones for treating tuberculosis". Cochrane Database Sys Rev (3): CD004795. डीओआई:10.1002/14651858.CD004795.pub2. पीएमआईडी 16034951.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Leimane V.; et al. (2005). "Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study". Lancet. 365 (9456): 318–26. डीओआई:10.1016/S0140-6736(05)17786-1. पीएमआईडी 15664227. {{cite journal}}: Explicit use of et al. in: |author= (help)
Schön T, Elias D, Moges F; et al. (2003). "Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis". Eur Respir J. 21 (3): 483–88. डीओआई:10.1183/09031936.03.00090702. पीएमआईडी 12662006. मूल से से 19 जनवरी 2010 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Rockett KA, Brookes R, Udalova I; et al. (November 1, 1998). "1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line". Infect Immunity. 66 (11): 5314–21. पीएमसी 108664. पीएमआईडी 9784538. मूल से से 5 जनवरी 2011 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Chambers HF, Turner J, Schecter GF, Kawamura M, Hopewell PC. (2005). "Imipenem for treatment of tuberculosis in mice and humans". Antimicrob Agents Chemother. 49 (7): 2816–21. डीओआई:10.1128/AAC.49.7.2816-2821.2005. पीएमसी 1168716. पीएमआईडी 15980354.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Chambers HF, Kocagoz T, Sipit T, Turner J, Hopewell PC. (1998). "Activity of amoxicillin/clavulanate in patients with tuberculosis". Clin Infect Dis. 26 (4): 874–7. डीओआई:10.1086/513945. पीएमआईडी 9564467.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Donald PR, Sirgel FA, Venter A; et al. (2001). "Early bactericidal activity of amoxicillin in combination with clavulanic acid in patients with sputum smear-positive pulmonary tuberculosis". Scand J Infect Dis. 33 (6): 466–9. डीओआई:10.1080/00365540152029954. पीएमआईडी 11450868. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Jagannath C, Reddy MV, Kailasam S, O'Sullivan JF, Gangadharam PR. (April 1, 1995). "Chemotherapeutic activity of clofazimine and its analogues against Mycobacterium tuberculosis. In vitro, intracellular, and in vivo studies". Am J Respir Crit Care Med. 151 (4): 1083–86. पीएमआईडी 7697235. मूल से से 16 जुलाई 2011 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Janulionis, E.; Sofer, C; Song, HY; Wallis, RS (2004). "Lack of activity of orally administered clofazimine against intracellular Mycobacterium tuberculosis in whole-blood culture" (PDF). Antimicrob Agents Chemother. 48 (8): 3133–35. डीओआई:10.1128/AAC.48.8.3133-3135.2004. पीएमसी 478499. पीएमआईडी 15273133. मूल से (PDF) से 21 जुलाई 2011 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011.
Shubin H, Sherson J, Pennes E, Glaskin A, Sokmensuer A. (1958). "Prochlorperazine (compazine) as an aid in the treatment of pulmonary tuberculosis". Antibiotic Med Clin Ther. 5 (5): 305–9. पीएमआईडी 13521769.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Wayne LG, Sramek HA (1994). "Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis". Antimicrob Agents Chemother. 38 (9): 2054–58. डीओआई:10.1128/AAC.. पीएमसी 284683. पीएमआईडी 7811018. मूल से से 5 जनवरी 2011 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011. {{cite journal}}: Check |doi= value (help)
Stover CK, Warrener P, VanDevanter DR; et al. (2000). "A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis". Nature. 405 (6789): 962–6. डीओआई:10.1038/35016103. पीएमआईडी 10879539. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Andries K, Verhasselt P, Guillemont J; et al. (2005). "A diarylquinoline drug active on the ATP-synthase of Mycobacterium tuberculosis". Science. 307 (5707): 223–27. डीओआई:10.1126/science.1106753. पीएमआईडी 15591164. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Harries AD; Hargreaves NJ, Kumwenda J, Kwanjana1 JH, Salaniponi1 FM (2000). "Trials of anti-tuberculosis treatment in areas of high human immunodeficiency virus prevalence in sub-Saharan Africa". Int J Tuberc Lung Dis. 4 (11): 998–1001. पीएमआईडी 11092710. 6 जून 2011 को मूल से पुरालेखित. अभिगमन तिथि: 22 फ़रवरी 2011.{{cite journal}}: CS1 maint: multiple names: authors list (link) CS1 maint: numeric names: authors list (link)
Fourie B, Weyer K (2000). "Trials of anti-tuberculosis treatment as a diagnostic tool in smear-negative tuberculosis are of questionable benefit". Int J Tuberc Lung Dis. 4 (11): 997. पीएमआईडी 11092709.
Chan ED, Laurel V, Strand MJ; et al. (2004). "Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis". Am J Resp Crit Care Med. 169 (10): 1103–1109. डीओआई:10.1164/rccm.200308-1159OC. पीएमआईडी 14742301. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
van Leuven M, De Groot M, Shean KP, von Oppell UO, Willcox PA (1997). "Pulmonary resection as an adjunct in the treatment of multiple drug-resistant tuberculosis". The Annals of thoracic surgery. 63 (5): 1368–72. पीएमआईडी 9146329. {{cite journal}}: Unknown parameter |unused_data= ignored (help)CS1 maint: multiple names: authors list (link)
Sung SW, Kang CH, Kim YT, Han SK, Shim YS, Kim JH (1999). "Surgery increased the chance of cure in multi-drug resistant pulmonary tuberculosis". Eur J Cardiothorac Surg. 16 (2): 187–93. डीओआई:10.1016/S1010-7940(99)00158-X. पीएमआईडी 10485419.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Pomerantz BJ, Cleveland JC Jr, Olson HK, Pomerantz M (2001). "Pulmonary resection for multi-drug resistant tuberculosis". J Thorac Cardiovasc Surg. 121 (3): 448–453. डीओआई:10.1067/mtc.2001.112339. पीएमआईडी 11241079.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Park SK, Lee CM, Heu JP, Song SD (2002). "A retrospective study for the outcome of pulmonary resection in 49 patients with multidrug-resistant tuberculosis". Int J Tuberc Lung Dis. 6 (2): 143–9}. पीएमआईडी 11931413.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Naidoo R, Reddi A (2005). "Lung resection for multidrug-resistant tuberculosis". Asian Cardiovasc Thorac Ann. 13 (2): 172–4. पीएमआईडी 15905349.
Shiraishi Y, Nakajima Y, Katsuragi N, Kurai M, Takahashi N (2004). "Resectional surgery combined with chemotherapy remains the treatment of choice for multidrug-resistant tuberculosis". J Thorac Cardiovasc Surg. 128 (4): 523–8. डीओआई:10.1016/S0022-5223(04)00871-2. पीएमआईडी 15457152.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Li WT, Jiang GN, Gao W, Xiao HP, Ding JA. 李文濤,姜格寧,高文,肖和平,丁嘉安 (2006). "Surgical treatment of multi-drug resistant pulmonary tuberculosis in 188 cases 耐多藥肺結核188例的外科治療". Chinese Journal of Tuberculosis and Respiratory Diseases 中華結核和呼吸雜誌 (चीनी भाषा में). 29 (8): 524–6. पीएमआईडी 17074264. मूल से से 9 जनवरी 2016 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011. {{cite journal}}: External link in |journal= (help)CS1 maint: multiple names: authors list (link)
Mohsen T, Zeid AA, Haj-Yahia S (2007). "Lobectomy or pneumonectomy for multidrug-resistant pulmonary tuberculosis can be performed with acceptable morbidity and mortality: A seven-year review of a single institution's experience". J Thorac Cardiovasc Surg. 134 (1): 194–198. डीओआई:10.1016/j.jtcvs.2007.03.022. पीएमआईडी 17599508.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Onwubalili JK. (1988). "Malnutrition among tuberculosis patients in Harrow, England". Eur J Clin Nutr. 42 (4): 363–6. पीएमआईडी 3396528.
Zachariah R, Spielmann MP, Harries AD, Salaniponi FM. (2002). "Moderate to severe malnutrition in patients with tuberculosis is a risk factor associated with early death". Trans R Soc Trop Med Hyg. 96 (3): 291–4. डीओआई:10.1016/S0035-9203(02)90103-3. पीएमआईडी 12174782.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Baldwin M; Yori, PP; Ford, C; Moore, DA; Gilman, RH; Vidal, C; Ticona, E; Evans, CA (2004). "Tuberculosis and nutrition: disease perceptions and health seeking behavior of household contacts in the Peruvian Amazon". Int J Tuberc Lung Dis. 8 (12): 1484–91. पीएमसी 2912521. पीएमआईडी 15636496.
Nnoaham KE, Clarke A (2008). "Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis". Int J Epidemiol. 37 (1): 113–9. डीओआई:10.1093/ije/dym247. पीएमआईडी 18245055.
Davies PD (1985). "A possible link between vitamin D deficiency and impaired host defence to Mycobacterium tuberculosis". Tubercle. 66 (4): 301–6. डीओआई:10.1016/0041-3879(85)90068-6. पीएमआईडी 3936248.
Liu PT, Stenger S, Li H; et al. (2006). "Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response". Science. 311 (5768): 1770–3. डीओआई:10.1126/science.1123933. पीएमआईडी 16497887. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Brodie MJ, Boobis AR, Hillyard CJ, Abeyasekera G, MacIntyre I, Park BK (1981). "Effect of isoniazid on vitamin D metabolism and hepatic monooxygenase activity". Clin Pharmacol Ther. 30 (3): 363–7. डीओआई:10.1038/clpt.1981.173. पीएमआईडी 7273600.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Brodie MJ, Boobis AR, Hillyard CJ; et al. (1982). "Effect of rifampicin and isoniazid on vitamin D metabolism". Clin Pharmacol Ther. 32 (4): 525–30. डीओआई:10.1038/clpt.1982.197. पीएमआईडी 7116768. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Perry W, Erooga MA, Brown J, Stamp TC (1982). "Calcium metabolism during rifampicin and isoniazid therapy for tuberculosis". J R Soc Med. 75 (7): 533–536. पीएमसी 1437875. पीएमआईडी 7086805.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Williams SE, Wardman AG, Taylor GA, Peacock M, Cooke NJ (1985). "Long term study of the effect of rifampicin and isoniazid on vitamin D metabolism". Tubercle. 66 (1): 49–54. डीओआई:10.1016/0041-3879(85)90053-4. पीएमआईडी 3838603.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Chan TY (1996). "Osteomalacia during rifampicin and isoniazid therapy is rare in Hong Kong". Int J Clin Pharmacol Ther. 34 (12): 533–4. पीएमआईडी 8996847.
Bellamy R, Ruwende C, Corrah T; et al. (1998). "Tuberculosis and chronic hepatitis B virus infection in africans and variation in the vitamin D receptor gene". J Infect Dis. 179 (3): 721–24. डीओआई:10.1086/314614. पीएमआईडी 9952386. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Wilkinson R, Llewelyn M, Toossi Z; et al. (2000). "Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study". Lancet. 355 (9204): 618–21. डीओआई:10.1016/S0140-6736(99)02301-6. पीएमआईडी 10696983. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
刘玮,张翠英,吴晓明; et al. (2003). "维生素D受体基因多态性与肺结核易感性的病例对照研究 (A case-control study on the vitamin D receptor gene polymorphisms and susceptibility to pulmonary tuberclosis)". 中华流行病学杂志 (Chinese Journal of Epidemiology) (चीनी भाषा में). 24 (5): 389–92. पीएमआईडी 12820934. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Wejse C, Gomes VF, Rabna P; et al. (2009). "Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial". Am J Respir Crit Care Med. 179 (9): 843–50. पीएमआईडी 19179490. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Spector SA (2009). "Vitamin D earns more than a passing grade". J Infect Dis. 200 (7): 1015–1017. डीओआई:10.1086/605723. पीएमआईडी 19673648.
Martineau AR, Wilkinson RJ, Wilkinson KA, Newton SM, Kampmann B, Hall BM; et al. (2007). "A single dose of vitamin D enhances immunity to Mycobacteria". Am J Respir Crit Care Med. 176 (2): 208–13. डीओआई:10.1164/rccm.200701-007OC. पीएमआईडी 17463418. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Rook GA, Steele J, Fraher L; et al. (1986). "Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes". Immunology. 57: 159–163. पीएमआईडी 3002968. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Crowle AJ, Ross EJ, May MH (1987). "Inhibition by l,25(OH)2-vitamin D3 of the multiplication of virulent tubercle bacilli in cultured human macrophages". Infect Immun. 55: 2945–2950. पीएमआईडी 3119492.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Coussens A,Timms PM, Boucher BJ; et al. (2009). "1α,25-dihydroxyvitamin D inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection". Immunology. 127 (4): 539–48. पीएमआईडी 19178594. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Schechter M, Zajdenverg R, Falco G, Barnes G, Faulhaber J, Coberly J, Moore R, Chaisson R (2006). "Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts". Am J Respir Crit Care Med. 173 (8): 922–6. डीओआई:10.1164/rccm.200512-1953OC. पीएमसी 2662911. पीएमआईडी 16474028.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Ijaz K, Jereb JA, Lambert LA; et al. (2006). "Severe of fatal liver injury in 50 patients in the United States taking rifampin and pyrazinamide for latent tuberculosis". Clin Infect Dis. 42 (3): 346–55. डीओआई:10.1086/499244. पीएमआईडी 16392079. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Nuermberger EL, Yoshimatsu T, Tyagi S; et al. (2004). "Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine Tuberculosis". Am J Resp Crit Care Med. 169 (3): 421–26. डीओआई:10.1164/rccm.200310-1380OC. पीएमआईडी 14578218. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Gosling RD, Uiso LO, Sam NE; et al. (2003). "The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis". Am J Resp Crit Care Med. 168 (11): 1342–45. डीओआई:10.1164/rccm.200305-682OC. पीएमआईडी 12917230. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Nuermberger EL, Yoshimatsu T, Tyagi S; et al. (2004). "Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis". Am J Resp Crit Care Med. 170 (10): 1131–34. डीओआई:10.1164/rccm.200407-885OC. पीएमआईडी 15306535. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Zaitzeva SI, Matveeva SL, Gerasimova TG; et al. (2009). "Treatment of cavitary and infiltrating pulmonary tuberculosis with and without the immunomodulator Dzherelo". Clinical Microbiology and Infection. 15 (12): 1154–62. डीओआई:10.1111/j.1469-0691.2009.02760.x. पीएमआईडी 19456829. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Nikolaeva LG, Maystat TV, Pylypchuk VS, Volyanskii YL, Frolov VM, Kutsyna GA (2008). "Cytokine profiles of HIV patients with pulmonary tuberculosis resulting from adjunct immunotherapy with herbal phytoconcentrates Dzherelo and Anemin". Cytokine. 44 (3): 392–6. डीओआई:10.1016/j.cyto.2008.10.009. पीएमआईडी 19027322. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Nikolaeva LG, Maystat TV, Pylypchuk VS, Volyanskii YL, Masyuk LA, Kutsyna GA (2008). "Effect of oral immunomodulator Dzherelo in TB/HIV co-infected patients receiving anti-tuberculosis therapy under DOTS". International Immunopharmacology. 8 (6): 845–51. डीओआई:10.1016/j.intimp.2008.01.029. पीएमआईडी 18442788. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)

ncbi.nlm.nih.gov

"Streptomycin treatment of pulmonary tuberculosis". British Medical Journal. 2 (4582): 769–82. 1948. डीओआई:10.1136/bmj.2.4582.769. पीएमसी 2091872. पीएमआईडी 18890300. {{cite journal}}: Unknown parameter |month= ignored (help)
Wang JY, Hsueh PR, Jan IS; et al. (2006). "Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas". Thorax. 61 (10): 903–8. डीओआई:10.1136/thx.2005.056887. पीएमसी 2104756. पीएमआईडी 16809417. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
David HL (1970). "Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis". Applied Microbiology. 20 (5): 810–4. पीएमसी 377053. पीएमआईडी 4991927. {{cite journal}}: Unknown parameter |month= ignored (help)
Sterling TR, Lehmann HP, Frieden TR (2003). "Impact of DOTS compared with DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths: decision analysis". BMJ. 326 (7389): 574. डीओआई:10.1136/bmj.326.7389.574. पीएमसी 151519. पीएमआईडी 12637401. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Peloquin CA, Bulpitt AE, Jaresko GS, Jelliffe RW, Childs JM, Nix DE (1999). "Pharmacokinetics of ethambutol under fasting conditions, with food, and with antacids". Antimicrobial Agents and Chemotherapy. 43 (3): 568–72. पीएमसी 89161. पीएमआईडी 10049268. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)^{[मृत कड़ियाँ]}
O'Riordan P, Schwab U, Logan S; et al. (2008). "Rapid molecular detection of rifampicin resistance facilitates early diagnosis and treatment of multidrug-resistant tuberculosis: case control study". PLoS ONE. 3 (9): e3173. डीओआई:10.1371/journal.pone.0003173. पीएमसी 2526158. पीएमआईडी 18779863. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link) CS1 maint: unflagged free DOI (link)
Sidley P. (2006). "South Africa acts to curb spread of lethal strain of TB". Brit Med J. 333 (7573): 825. डीओआई:10.1136/bmj.333.7573.825-a. पीएमसी 1618468. पीएमआईडी 17053232.
Singh JA, Upshur R, Padayatchi N. (2007). "XDR-TB in South Africa: No Time for Denial or Complacency". PLoS Med. 4 (1): e50. डीओआई:10.1371/journal.pmed.0040050. पीएमसी 1779818. पीएमआईडी 17253901.{{cite journal}}: CS1 maint: multiple names: authors list (link) CS1 maint: unflagged free DOI (link)
Bang D, Andersen ÅB, Thomsen VØ (2006). "Rapid genotypic detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis directly in clinical specimens". J Clin Microbiol. 44 (7): 2605–2608. डीओआई:10.1128/JCM.00752-06. पीएमसी 1489488. पीएमआईडी 16825393.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Rockett KA, Brookes R, Udalova I; et al. (November 1, 1998). "1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line". Infect Immunity. 66 (11): 5314–21. पीएमसी 108664. पीएमआईडी 9784538. मूल से से 5 जनवरी 2011 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Chambers HF, Turner J, Schecter GF, Kawamura M, Hopewell PC. (2005). "Imipenem for treatment of tuberculosis in mice and humans". Antimicrob Agents Chemother. 49 (7): 2816–21. डीओआई:10.1128/AAC.49.7.2816-2821.2005. पीएमसी 1168716. पीएमआईडी 15980354.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Janulionis, E.; Sofer, C; Song, HY; Wallis, RS (2004). "Lack of activity of orally administered clofazimine against intracellular Mycobacterium tuberculosis in whole-blood culture" (PDF). Antimicrob Agents Chemother. 48 (8): 3133–35. डीओआई:10.1128/AAC.48.8.3133-3135.2004. पीएमसी 478499. पीएमआईडी 15273133. मूल से (PDF) से 21 जुलाई 2011 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011.
Wayne LG, Sramek HA (1994). "Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis". Antimicrob Agents Chemother. 38 (9): 2054–58. डीओआई:10.1128/AAC.. पीएमसी 284683. पीएमआईडी 7811018. मूल से से 5 जनवरी 2011 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011. {{cite journal}}: Check |doi= value (help)
Baldwin M; Yori, PP; Ford, C; Moore, DA; Gilman, RH; Vidal, C; Ticona, E; Evans, CA (2004). "Tuberculosis and nutrition: disease perceptions and health seeking behavior of household contacts in the Peruvian Amazon". Int J Tuberc Lung Dis. 8 (12): 1484–91. पीएमसी 2912521. पीएमआईडी 15636496.
Perry W, Erooga MA, Brown J, Stamp TC (1982). "Calcium metabolism during rifampicin and isoniazid therapy for tuberculosis". J R Soc Med. 75 (7): 533–536. पीएमसी 1437875. पीएमआईडी 7086805.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Schechter M, Zajdenverg R, Falco G, Barnes G, Faulhaber J, Coberly J, Moore R, Chaisson R (2006). "Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts". Am J Respir Crit Care Med. 173 (8): 922–6. डीओआई:10.1164/rccm.200512-1953OC. पीएमसी 2662911. पीएमआईडी 16474028.{{cite journal}}: CS1 maint: multiple names: authors list (link)
PMID 18455842

omicsonline.org

Olga V. Arjanova; Athalia D. Prihoda1; Larisa V. Yurchenko1; Nina I. Sokolenko1; Valery M. Frolov; Marina G Tarakanovskaya; Vichai Jirathitikal; Aldar S. Bourinbaiar (अक्टूबर 9, 2010). "Phase 2 Trial of V-5 Immunitor (V5) in Patients with Chronic Hepatitis C Co-infected with HIV and Mycobacterium Tuberculosis". Journal of Vaccines and Vaccination. 1 (103). डीओआई:10.4172/2157-7560.1000103. मूल से से 1 जनवरी 2011 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011.{{cite journal}}: CS1 maint: numeric names: authors list (link) CS1 maint: unflagged free DOI (link)

periodicals.net.cn

zhjhhhx.periodicals.net.cn

Li WT, Jiang GN, Gao W, Xiao HP, Ding JA. 李文濤,姜格寧,高文,肖和平,丁嘉安 (2006). "Surgical treatment of multi-drug resistant pulmonary tuberculosis in 188 cases 耐多藥肺結核188例的外科治療". Chinese Journal of Tuberculosis and Respiratory Diseases 中華結核和呼吸雜誌 (चीनी भाषा में). 29 (8): 524–6. पीएमआईडी 17074264. मूल से से 9 जनवरी 2016 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011. {{cite journal}}: External link in |journal= (help)CS1 maint: multiple names: authors list (link)

proactiveinvestors.co.uk

"Stirling Products inks deal with Innovative Biotech to trial Immunoxel in Nigeria - Proactiveinvestors (UK)". मूल से से 22 जुलाई 2011 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011.

reuters.com

go.reuters.com

Sarah McGregor. "New TB strain could fuel South Africa AIDS toll". Reuters. मूल से से 2 नवंबर 2005 को पुरालेखित।. अभिगमन तिथि: 2006-09-17. {{cite web}}: Check date values in: |archive-date= (help)

scialert.net

"Adjuvant Immunotherapy of Extensively Drug-Resistant Tuberculosis (XDR-TB) in Ukraine". मूल से से 23 जुलाई 2011 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011.

tballiance.org

TB Alliance. "TB Alliance and Bayer launch historic global TB drug trials". मूल से से 25 सितंबर 2006 को पुरालेखित।. अभिगमन तिथि: 2006-10-17.

uchicago.edu

journals.uchicago.edu

Drobac PC; et al. (2005). "Treatment of Multidrug-Resistant Tuberculosis during Pregnancy: Long-Term Follow-Up of 6 Children with Intrauterine Exposure to Second-Line Agents" (– ^{Scholar search}). Clin Infect Dis. 40 (11): 1689–92. डीओआई:10.1086/430066. पीएमआईडी 15889370. {{cite journal}}: Explicit use of et al. in: |author= (help); External link in |format= (help) ^{[मृत कड़ियाँ]}
Palacios E, Dallman R, Muñoz M; et al. (2009). "Drug‐resistant tuberculosis and pregnancy: Treatment outcomes of 38 cases in Lima, Peru". Clin Infect Dis. 48 (10): 1413–1419. डीओआई:10.1086/598191. पीएमआईडी 19361302. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Jenny‐Avital1 ER, Joseph K (2009). "Rifamycin‐resistant Mycobacterium tuberculosis in the highly active antiretroviral therapy era: A report of 3 relapses with acquired rifampin resistance following alternate‐day rifabutin and boosted protease inhibitor therapy". Clin Infect Dis. 48 (10): 1471–1474. डीओआई:10.1086/598336. पीएमआईडी 19368504.{{cite journal}}: CS1 maint: numeric names: authors list (link)

web.archive.org

World Health Organisation. "WHO Global Task Force outlines measures to combat XDR-TB worldwide". 1 नवंबर 2013 को मूल से पुरालेखित. अभिगमन तिथि: 2006-10-21. {{cite web}}: Check date values in: |archive-date= (help)
Center for Disease Control (2006). "Emergence of Mycobacterium tuberculosis with Extensive Resistance to Second-Line Drugs — Worldwide, 2000–2004". MMWR Weekly. 55 (11): 301–305. 12 जनवरी 2020 को मूल से पुरालेखित. अभिगमन तिथि: 22 फ़रवरी 2011.
Sarah McGregor. "New TB strain could fuel South Africa AIDS toll". Reuters. मूल से से 2 नवंबर 2005 को पुरालेखित।. अभिगमन तिथि: 2006-09-17. {{cite web}}: Check date values in: |archive-date= (help)
Centers for Diseases Control (2006). "Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000-2004". Morb Mort Wkly Rep. 55: 301–5. 10 मार्च 2010 को मूल से पुरालेखित. अभिगमन तिथि: 22 फ़रवरी 2011.
Migliori GB, Ortmann J, Girardi E; et al. (2007). "Extensively drug-resistant tuberculosis, Italy and Germany". 13 (5). 10 मार्च 2010 को मूल से पुरालेखित. अभिगमन तिथि: 22 फ़रवरी 2011. {{cite journal}}: Cite journal requires |journal= (help); Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Mitnick C; et al. (2003). "Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru". N Eng J Med. 348 (2): 119–128. डीओआई:10.1056/NEJMoa022928. पीएमआईडी 12519922. 18 फ़रवरी 2009 को मूल से पुरालेखित. अभिगमन तिथि: 22 फ़रवरी 2011. {{cite journal}}: Explicit use of et al. in: |author= (help)
"Old drug combination in TB fight". बीबीसी न्यूज़. 27 फ़रवरी 2009. 1 मार्च 2009 को मूल से पुरालेखित. अभिगमन तिथि: 27 फ़रवरी 2009.
Schön T, Elias D, Moges F; et al. (2003). "Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis". Eur Respir J. 21 (3): 483–88. डीओआई:10.1183/09031936.03.00090702. पीएमआईडी 12662006. मूल से से 19 जनवरी 2010 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Rockett KA, Brookes R, Udalova I; et al. (November 1, 1998). "1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line". Infect Immunity. 66 (11): 5314–21. पीएमसी 108664. पीएमआईडी 9784538. मूल से से 5 जनवरी 2011 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Jagannath C, Reddy MV, Kailasam S, O'Sullivan JF, Gangadharam PR. (April 1, 1995). "Chemotherapeutic activity of clofazimine and its analogues against Mycobacterium tuberculosis. In vitro, intracellular, and in vivo studies". Am J Respir Crit Care Med. 151 (4): 1083–86. पीएमआईडी 7697235. मूल से से 16 जुलाई 2011 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Adams LM, Sinha I, Franzblau SG; et al. (1999). "Effective treatment of acute and chronic murine tuberculosis with liposome-encapsulated clofazimine" (PDF). Antimicrob Agents Chemother. 43 (7): 1638–43. मूल से (PDF) से 21 जुलाई 2011 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Janulionis, E.; Sofer, C; Song, HY; Wallis, RS (2004). "Lack of activity of orally administered clofazimine against intracellular Mycobacterium tuberculosis in whole-blood culture" (PDF). Antimicrob Agents Chemother. 48 (8): 3133–35. डीओआई:10.1128/AAC.48.8.3133-3135.2004. पीएमसी 478499. पीएमआईडी 15273133. मूल से (PDF) से 21 जुलाई 2011 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011.
Wayne LG, Sramek HA (1994). "Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis". Antimicrob Agents Chemother. 38 (9): 2054–58. डीओआई:10.1128/AAC.. पीएमसी 284683. पीएमआईडी 7811018. मूल से से 5 जनवरी 2011 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011. {{cite journal}}: Check |doi= value (help)
Harries AD; Hargreaves NJ, Kumwenda J, Kwanjana1 JH, Salaniponi1 FM (2000). "Trials of anti-tuberculosis treatment in areas of high human immunodeficiency virus prevalence in sub-Saharan Africa". Int J Tuberc Lung Dis. 4 (11): 998–1001. पीएमआईडी 11092710. 6 जून 2011 को मूल से पुरालेखित. अभिगमन तिथि: 22 फ़रवरी 2011.{{cite journal}}: CS1 maint: multiple names: authors list (link) CS1 maint: numeric names: authors list (link)
Li WT, Jiang GN, Gao W, Xiao HP, Ding JA. 李文濤,姜格寧,高文,肖和平,丁嘉安 (2006). "Surgical treatment of multi-drug resistant pulmonary tuberculosis in 188 cases 耐多藥肺結核188例的外科治療". Chinese Journal of Tuberculosis and Respiratory Diseases 中華結核和呼吸雜誌 (चीनी भाषा में). 29 (8): 524–6. पीएमआईडी 17074264. मूल से से 9 जनवरी 2016 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011. {{cite journal}}: External link in |journal= (help)CS1 maint: multiple names: authors list (link)
TB Alliance. "TB Alliance and Bayer launch historic global TB drug trials". मूल से से 25 सितंबर 2006 को पुरालेखित।. अभिगमन तिथि: 2006-10-17.
Prihoda et al. Archived 2010-11-15 at the वेबैक मशीन Open label trial of adjuvant immunotherapy with Dzherelo, Svitanok and Lizorm, in MDR-TB, XDR-TB and TB/HIV co-infected patients receiving anti-tuberculosis ther... Archived 2010-11-15 at the वेबैक मशीन
"Adjuvant Immunotherapy of Extensively Drug-Resistant Tuberculosis (XDR-TB) in Ukraine". मूल से से 23 जुलाई 2011 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011.
"Stirling Products inks deal with Innovative Biotech to trial Immunoxel in Nigeria - Proactiveinvestors (UK)". मूल से से 22 जुलाई 2011 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011.
Olga V. Arjanova; Athalia D. Prihoda1; Larisa V. Yurchenko1; Nina I. Sokolenko1; Valery M. Frolov; Marina G Tarakanovskaya; Vichai Jirathitikal; Aldar S. Bourinbaiar (अक्टूबर 9, 2010). "Phase 2 Trial of V-5 Immunitor (V5) in Patients with Chronic Hepatitis C Co-infected with HIV and Mycobacterium Tuberculosis". Journal of Vaccines and Vaccination. 1 (103). डीओआई:10.4172/2157-7560.1000103. मूल से से 1 जनवरी 2011 को पुरालेखित।. अभिगमन तिथि: 22 फ़रवरी 2011.{{cite journal}}: CS1 maint: numeric names: authors list (link) CS1 maint: unflagged free DOI (link)

who.int

World Health Organisation. "WHO Global Task Force outlines measures to combat XDR-TB worldwide". 1 नवंबर 2013 को मूल से पुरालेखित. अभिगमन तिथि: 2006-10-21. {{cite web}}: Check date values in: |archive-date= (help)

wikipedia.org

en.wikipedia.org

Parthasarathy R, Sriram K, Santha T, Prabhakar R, Somasundaram PR, Sivasubramanian S (1999). "Short-course chemotherapy for tuberculosis of the spine. A comparison between ambulant treatment and radical surgery--ten-year report". The Journal of Bone and Joint Surgery. British Volume. 81 (3): 464–71. पीएमआईडी 10872368. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)^{[मृत कड़ियाँ]}
Peloquin CA, Bulpitt AE, Jaresko GS, Jelliffe RW, Childs JM, Nix DE (1999). "Pharmacokinetics of ethambutol under fasting conditions, with food, and with antacids". Antimicrobial Agents and Chemotherapy. 43 (3): 568–72. पीएमसी 89161. पीएमआईडी 10049268. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)^{[मृत कड़ियाँ]}
Drobac PC; et al. (2005). "Treatment of Multidrug-Resistant Tuberculosis during Pregnancy: Long-Term Follow-Up of 6 Children with Intrauterine Exposure to Second-Line Agents" (– ^{Scholar search}). Clin Infect Dis. 40 (11): 1689–92. डीओआई:10.1086/430066. पीएमआईडी 15889370. {{cite journal}}: Explicit use of et al. in: |author= (help); External link in |format= (help) ^{[मृत कड़ियाँ]}
Angela Quintal. "314 XDR-TB cases reported in SA". Cape Times. अभिगमन तिथि: 2007-04-04.^{[मृत कड़ियाँ]}
News24. 2-7-1442_2035020,00.html "300+ cases of killer TB in SA". अभिगमन तिथि: 2006-11-23. {{cite web}}: Check |url= value (help)CS1 maint: numeric names: authors list (link)^{[मृत कड़ियाँ]}

yahoo.com

uk.f233.mail.yahoo.com

Angela Quintal. "314 XDR-TB cases reported in SA". Cape Times. अभिगमन तिथि: 2007-04-04.^{[मृत कड़ियाँ]}